Targeting the fungal cell wall: current therapies and implications for development of alternative antifungal agents
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting the fungal cell wall: current therapies and implications for development of alternative antifungal agents
Authors
Keywords
-
Journal
Future Medicinal Chemistry
Volume 11, Issue 8, Pages 869-883
Publisher
Future Science Ltd
Online
2019-04-17
DOI
10.4155/fmc-2018-0465
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Activity of CD101, a long-acting echinocandin, against clinical isolates of Candida auris
- (2018) Elizabeth L. Berkow et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Fungal Morphogenesis, from the Polarized Growth of Hyphae to Complex Reproduction and Infection Structures
- (2018) Meritxell Riquelme et al. MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS
- Epidemiology of fungal infections in China
- (2018) Min Chen et al. Frontiers of Medicine
- CD101, a long-acting echinocandin, and comparator antifungal agents tested against a global collection of invasive fungal isolates in the SENTRY 2015 Antifungal Surveillance Program
- (2017) Michael A. Pfaller et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Nanoparticles as safe and effective delivery systems of antifungal agents: Achievements and challenges
- (2017) Ghareb M. Soliman INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Portrait of Candida Species Biofilm Regulatory Network Genes
- (2017) Daniela Araújo et al. TRENDS IN MICROBIOLOGY
- CD101: a novel long-acting echinocandin
- (2016) Yanan Zhao et al. CELLULAR MICROBIOLOGY
- Evolutionary history of the chitin synthases of eukaryotes
- (2016) Alexey A Morozov et al. GLYCOBIOLOGY
- β-(1,3)-Glucan Unmasking in Some Candida albicans Mutants Correlates with Increases in Cell Wall Surface Roughness and Decreases in Cell Wall Elasticity
- (2016) Sahar Hasim et al. INFECTION AND IMMUNITY
- CD101, a novel echinocandin with exceptional stability properties and enhanced aqueous solubility
- (2016) B Radha Krishnan et al. JOURNAL OF ANTIBIOTICS
- Epidemiology and molecular mechanisms of antifungal resistance in CandidaandAspergillus
- (2016) Sarah Santos Gonçalves et al. MYCOSES
- Candida albicans Agglutinin-Like Sequence (Als) Family Vignettes: A Review of Als Protein Structure and Function
- (2016) Lois L. Hoyer et al. Frontiers in Microbiology
- Antifungal Activities of SCY-078 (MK-3118) and Standard Antifungal Agents against Clinical Non-Aspergillus Mold Isolates
- (2015) Frédéric Lamoth et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Caspofungin: Pharmacodynamics, pharmacokinetics, clinical uses and treatment outcomes
- (2015) Jessica C. Song et al. CRITICAL REVIEWS IN MICROBIOLOGY
- Dissecting the function of the different chitin synthases in vegetative growth and sexual development in Neurospora crassa
- (2015) Rosa A. Fajardo-Somera et al. FUNGAL GENETICS AND BIOLOGY
- Molecular Interactions of β-(1→3)-Glucans with Their Receptors
- (2015) Laurent Legentil et al. MOLECULES
- Pharmacodynamic Target Evaluation of a Novel Oral Glucan Synthase Inhibitor, SCY-078 (MK-3118), Using anIn VivoMurine Invasive Candidiasis Model
- (2014) Alexander J. Lepak et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Novel antifungal agents: a patent review (2011 – present)
- (2014) María Victoria Castelli et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Candida albicans Hypha Formation and Mannan Masking of β-Glucan Inhibit Macrophage Phagosome Maturation
- (2014) Judith M. Bain et al. mBio
- Enfumafungin Derivative MK-3118 Shows IncreasedIn VitroPotency against Clinical Echinocandin-Resistant Candida Species and Aspergillus Species Isolates
- (2013) Cristina Jiménez-Ortigosa et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Hyphae-Specific Genes HGC1, ALS3, HWP1, and ECE1 and Relevant Signaling Pathways in Candida albicans
- (2013) Yan Fan et al. MYCOPATHOLOGIA
- The Mnn2 Mannosyltransferase Family Modulates Mannoprotein Fibril Length, Immune Recognition and Virulence of Candida albicans
- (2013) Rebecca A. Hall et al. PLoS Pathogens
- Aspergillus fumigatus—What Makes the Species a Ubiquitous Human Fungal Pathogen?
- (2013) Kyung J. Kwon-Chung et al. PLoS Pathogens
- Differential Adaptation of Candida albicans In Vivo Modulates Immune Recognition by Dectin-1
- (2013) Mohlopheni J. Marakalala et al. PLoS Pathogens
- In Vitro Activity of a New Oral Glucan Synthase Inhibitor (MK-3118) Tested against Aspergillus spp. by CLSI and EUCAST Broth Microdilution Methods
- (2012) M. A. Pfaller et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The biology and chemistry of antifungal agents: A review
- (2012) Muthu K Kathiravan et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Activity of MK-3118, a new oral glucan synthase inhibitor, tested against Candida spp. by two international methods (CLSI and EUCAST)
- (2012) M. A. Pfaller et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Hidden Killers: Human Fungal Infections
- (2012) G. D. Brown et al. Science Translational Medicine
- In VitroActivity of E1210, a Novel Antifungal, against Clinically Important Yeasts and Molds
- (2011) Mamiko Miyazaki et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- E1210, a New Broad-Spectrum Antifungal, Suppresses Candida albicans Hyphal Growth through Inhibition of Glycosylphosphatidylinositol Biosynthesis
- (2011) Nao-aki Watanabe et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activities of E1210 and Comparator Agents Tested by CLSI and EUCAST Broth Microdilution Methods against Fusarium and Scedosporium Species Identified Using Molecular Methods
- (2011) Mariana Castanheira et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Current perspectives on echinocandin class drugs
- (2011) David S Perlin Future Microbiology
- Enhancement of pradimicin production in Actinomadura hibisca P157-2 by metabolic engineering
- (2011) Sarita Paudel et al. MICROBIOLOGICAL RESEARCH
- EPIDEMIOLOGY OF INVASIVE FUNGAL INFECTIONS IN THE MEDITERRANEAN AREA
- (2011) Ulrike Binder et al. Mediterranean Journal of Hematology and Infectious Diseases
- Plagiochin E, an antifungal active macrocyclic bis(bibenzyl), induced apoptosis in Candida albicans through a metacaspase-dependent apoptotic pathway
- (2010) Xiu-Zhen Wu et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Syk-coupled C-type lectin receptors that mediate cellular activation via single tyrosine based activation motifs
- (2010) Ann M. Kerrigan et al. IMMUNOLOGICAL REVIEWS
- Effect of plagiochin E, an antifungal macrocyclic bis(bibenzyl), on cell wall chitin synthesis in Candida albicans
- (2009) Xiu-zhen Wu et al. ACTA PHARMACOLOGICA SINICA
- Fungal echinocandin resistance
- (2009) Louise A. Walker et al. FUNGAL GENETICS AND BIOLOGY
- Cell Wall β-(1,6)-Glucan ofSaccharomyces cerevisiae
- (2009) Vishukumar Aimanianda et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Evolution of pathogenicity and sexual reproduction in eight Candida genomes
- (2009) Geraldine Butler et al. NATURE
- Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
- (2008) Thomas J. Walsh et al. CLINICAL INFECTIOUS DISEASES
- Histoplasma capsulatum pathogenesis: making a lifestyle switch
- (2008) Eric D Holbrook et al. CURRENT OPINION IN MICROBIOLOGY
- Plagiochin E, a botanic-derived phenolic compound, reverses fungal resistance to fluconazole relating to the efflux pump
- (2008) X.-L. Guo et al. JOURNAL OF APPLIED MICROBIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now